Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer

Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells

(2014) HONG-QUAN DUONG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours

(2014) Monika Michałowska et al.   PLoS One

Embryonic stem cell factors and pancreatic cancer

(2014) Marta Herreros-Villanueva   WORLD JOURNAL OF GASTROENTEROLOGY

The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy

(2013) François Ghiringhelli et al.   Expert Review of Clinical Immunology

Determination of apoptotic and necrotic cell death in vitro and in vivo

(2013) Tom Vanden Berghe et al.   METHODS

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells

(2013) Sang Kyum Kim et al.   PLoS One

Current Knowledge on Pancreatic Cancer

(2012) Juan Iovanna et al.   Frontiers in Oncology

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

(2011) Stefano Cereda et al.   CHEMOTHERAPY

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?

(2011) Nicolas Penel et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems

(2011) Cristina Fillat et al.   Cancers

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

(2010) Peter J. Campbell et al.   NATURE

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

An original administration of ifosfamide given once every other week: a clinical and pharmacological study

(2009) Wulfran Cacheux et al.   ANTI-CANCER DRUGS

New Ifosfamide Analogs Designed for Lower Associated Neurotoxicity and Nephrotoxicity with Modified Alkylating Kinetics Leading to Enhanced in Vitro Anticancer Activity

(2008) T. Storme et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS